Cancer affects not just the patient but everyone around them With the right support from medical teams family friends and ...

The Oliver Patch Project was born. Three years after launching, the charity has provided more than 1,600 children from ...

Leukaemia UK are calling for a commitment from the UK Government to double the five-year survival rate for Acute Myeloid ...

Cipla has received final US FDA approval for its Nilotinib Capsules (50 mg, 150 mg, 200 mg) for the treatment of Philadelphia ...

China's National Medical Products Administration has approved a Phase III trial of InnoCare Pharma’s ICP-248 (Mesutoclax) ...

Acute myeloid leukaemia, or AML, is an aggressive blood cancer and requires immediate attention. AML is treatable with various approaches, depending on the patient's age and health status.

In the subgroup with 17p deletion or TP53 mutation, zanubrutinib outperformed others with the most favorable HR (0.52) and the highest SUCRA value of 97%.

The CRISTALLO trial showed that venetoclax plus obinutuzumab achieved high minimal residual disease negativity as a frontline ...

Cops for Kids with Cancer seeks to remove the financial burden for families impacted by a cancer diagnosis. This week they ...

Research suggests that people with CLL may be more likely to develop COVID-19 due to advanced age, disease-related immunosuppression, and treatment-related immunosuppression. Taking precautions ...

Quality-of-life (QOL) outcomes vary widely for patients receiving first-line treatment for chronic lymphocytic leukemia (CLL), according to research presented at the 2024 American Society of ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...